Telaprevir or simeprevir-based triple therapy for recurrent hepatitis C virus among living donor liver transplant recipients
Not Applicable
- Conditions
- Chronic hepatitis C after living donor liver transplantation
- Registration Number
- JPRN-UMIN000013628
- Lead Sponsor
- Hepato-Biliary-Pancreatic Surgery Division, and Artificial Organ and Transplantation Division
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
other than the above
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sustained virologic response rates
- Secondary Outcome Measures
Name Time Method